Application Nr Approved Date Route Status External Links
ANDA204243 2016-12-27 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Indomethacin Extended-Release Capsules Are Indicated For: Moderate To Severe Rheumatoid Arthritis Including Acute Flares Of Chronic Disease Moderate To Severe Ankylosing Spondylitis Moderate To Severe Osteoarthritis Acute Painful Shoulder (bursitis And/or Tendinitis) Indomethacin Extended-Release Capsules Are A Nonsteroidal Anti-Inflammatory Drug Indicated For: Moderate To Severe Rheumatoid Arthritis Including Acute Flares Of Chronic Disease Moderate To Severe Ankylosing Spondylitis Moderate To Severe Osteoarthritis Acute Painful Shoulder (bursitis And/or Tendinitis) (1)

All Formulated Excipients (1 Total)

Name Structure Kind Function Status
1. Sodium Lauryl Sulfate SODIUM LAURYL SULFATE Molecular AF-Antifoaming (or defoaming) agent , CTG-Component or coating , EMUL-Emulsifier , SANI-Sanitizing agent , SDA-Solubilizing & dispersing agent REG-Food additives for which a petition has been filed and a regulation issued.

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Indomethacin INDOMETHACIN ZINC601283

Comments